Skip to main content

Table 1 Phyllanthus urinaria koreanis extract inhibits replication of HBV WT and LMV-resistant mutants

From: Inhibitory effect of Phyllanthus urinaria L. extract on the replication of lamivudine-resistant hepatitis B virus in vitro

 

HBV DNA by Southern blottinga

HBV DNA by qPCRb

HBs Ag

HBc Ag

 

EC50c

EC90d

SIe

EC50c

EC90d

SIe

EC50c

SIe

EC50c

SIe

HBV WT

78.6 ± 1.3

154.8 ± 11.8

9.63

119.8 ± 21.2

228.2 ± 11.8

6.31

252.5 ± 27.0

2.99

185.9 ± 30.1

4.09

YIDD

82.3 ± 18.6

183.1 ± 22.3

9.19

125.2 ± 18.6

234.7 ± 22.3

6.04

239.5 ± 16.3

3.16

234.4 ± 19.3

3.23

YVDD

104.6 ± 9.2

179.4 ± 32.4

7.23

126.1 ± 9.2

228.2 ± 11.8

6.00

263.7 ± 10.4

2.87

241.3 ± 25.3

3.14

YSDD

90.1 ± 13.2

192.3 ± 22.6

6.91

139.8 ± 33.7

242.6 ± 32.4

5.4

ND

ND

195.6 ± 20.2

3.87

  1. Each value represents the mean ± SD from three independent experiments. HBV DNA was extracted from isolated intracellular core particles after various concentrations of Phyllanthus urinaria koreanis extract treatment for 48 h from HBV WT and mutant-transfected HepG2 cells
  2. ND not determined
  3. aHBV DNA level was measured by Southern blotting using Fujifilm Image Gauge V 4.0 program
  4. bHBV DNA level was measured by real-time quantitative PCR. Primers for pRCR are listed in Additional file 1
  5. cEC50 is the concentration at which 50 % depression of HBV DNA and HBs/e Ag secretion was observed
  6. dEC90 is the concentration at which 90 % depression of HBV DNA was observed
  7. eSelectivity index (SI) was calculated by EC50/CC50. CC50 of extract on HepG2 cells was 757.0 ± 56.5 μg/ml.CC50, the drug concentration that reduced cell viability to 50 % of that the control was determined by MTT assay